Search results
Showing 7851 to 7900 of 8201 results
NICE and PHE recommend all employers give mental health training for managers
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
NICE announces details of health technology evaluation methods review
Following approval at its recent Board meeting NICE has confirmed the details of its review of the methods it uses to develop guidance on drugs, medical devices and diagnostics.
NICE Chairman, Sharmila Nebhrajani, today announced Dr Samantha Roberts as incoming Chief Executive.
NICE announces more people eligible for nusinersen following review of Managed Access Agreement
NICE has today (4 May 2021) announced that more people with the rare genetic disorder spinal muscular atrophy (SMA) are to benefit from nusinersen (also called Spinraza and made by Biogen) following a review of data collected as part of the Managed Access Agreement (MAA).
NICE recognises the importance to patients of the updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) and is keen to move forwards as quickly as possible.
NICE announces next steps for publication of its guideline on ME/CFS
NICE has today (20 October 2021) announced the next steps for publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
NICE announces start of review of nusinersen Managed Access Agreement
NICE has today (29 October 2020) announced that it has begun the process to review data collected as part of the Managed Access Agreement (MAA) for nusinersen (also called Spinraza and made by Biogen) for treating the rare genetic disorder spinal muscular atrophy (SMA).
Professor Gillian Leng, CBE, appointed as new NICE Chief Executive
NICE has today (18 March 2020) announced that Professor Gillian Leng, CBE, has been appointed as its new Chief Executive.
NICE has appointed Dr Rosie Benneyworth, a GP and former commissioner, as a new Non-Executive Director (NED) to its Board.
NICE has announced the appointment of two new directors to key positions in newly formed directorates.
New NICE guideline to help people take control of their asthma could save the NHS millions
NICE has issued draft guidance setting out what medicines adults, young people and children with asthma should take to control symptoms and reduce asthma attacks.
NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.
New NICE quality standard identifies improvements in UTI diagnosis for women
Health professionals should diagnose women under 65 with a urinary tract infection (UTI) if they have two or more key urinary symptoms according to a new quality standard published by NICE today (15 February 2023).
New online and mobile app for depression should be trialled on the NHS, says NICE
NICE says that online and mobile programme Deprexis could help adults with depression get faster access to care and it should be tested out in NHS services.
Around 5,700 cases of multiple myeloma are diagnosed each year in the UK
New quality standards for public health - NICE wants your views
NICE is to develop a library of public health quality standards, in areas ranging from heatwave planning to sexual health, and is inviting stakeholders to comment on exactly which topics should be referred to NICE to develop.
New quality standards to help care homes manage medicines safely and prevent falls in older people
Two new quality standards on managing medicines in care homes and preventing falls will help to improve the quality of care for older people.
NICE has welcomed proposed new guidelines on alcohol which aim to limit the health risks that result from drinking.
Midwives should diagnose women with gestational diabetes if they either have a fasting plasma glucose level of 5.6 mmol/litre or above, or a 2-hour plasma glucose level of 7.8 mmol/litre or above, according to NICE.
New treatment approved for adolescents with bipolar disorder
NICE has recommended the use of aripiprazole (Abilify) as an option for treating moderate to severe manic episodes in adolescents with bipolar disorder.
New treatment to increase the chances of a successful kidney transplant recommended by NICE
A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance today (16 June 2022).
New video to support mental wellbeing of older people in care homes quality standard
A new film commissioned by the NICE collaborating centre for social care will help organisations and people use the quality standard on mental wellbeing of older people
New ways to diagnose and manage asthma can improve care, says NICE
New tests to help diagnose asthma and a change in how medicines are offered can help people take control of their asthma, NICE says in new guidance.
NICE has today (18 November 2021) published draft guidance recommending the first long-acting injectable treatment for HIV-1 infection in adults.
NICE approves first treatment in pilot of new approach to cost-comparison fast track appraisals
As part of the recovery from the COVID-19 pandemic, NICE has been working hard to find new ways to develop and publish guidance affected by the work programme pause in 2020, while also delivering the planned programme for 2021.
NICE approves ground-breaking cholesterol-lowering drug inclisiran
NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke.
NICE final draft guidance approves life-changing gene therapy for treating spinal muscular atrophy
A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE.
Patients with atrial fibrillation can now be offered rivaroxaban (Xarelto), as an alternative to warfarin, in order to reduce their risk of stroke and blood clots, says NICE.
NICE approves routine use of drug combination for advanced breast cancer
Another life-extending drug combination for some people with advanced breast cancer will now be available for routine use in the NHS following its approval by NICE in final draft guidance published today (23 September 2022).
NICE approves sickle cell device that could save NHS £13m per year
NICE has recommended a new device for managing sickle cell disease that makes treatment for the condition easier and quicker, and could save the NHS around £13 million per year.
NICE approves treatment for hep C in its 300th technology appraisal
NICE has recommended the use of peginterferon alfa in combination with ribavirin to treat chronic hepatitis C in children and young people, in its 300th piece of technology appraisal guidance.
NICE backed award for physiotherapist helping to improve patients' quality of life
Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards
NICE has begun a phased restart of publishing non-COVID-19 guidance as the NHS and wider health and care system start to return to normal arrangements.
NICE to reinforce the importance of collaborative working with system partners to ensure a more integrated approach to safety recommendations made in NICE guidance
NICE calls for further research into the treatment of chronic lipoedema
NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.
NICE calls on care homes to prioritise the oral health of residents
Care home residents should be helped to brush their teeth twice a day, says NICE
Local government can improve the health and wellbeing of their communities, and save money in the long-term, by encouraging people to be more physically active, says NICE.
NICE is delighted to announce that today (26 May 2020) Sharmila Nebhrajani, OBE, has taken up her position as its new chairman following her appointment by the Secretary of State for Health and Social Care and an independent open recruitment process.
Professor Martin Cowie stands down from the NICE board following his appointment to a role at Astra Zeneca
NICE and the Canadian Agency for Drugs and Technology in Health (CADTH) have launched a new collaboration to offer parallel scientific advice to the life sciences industry.
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
NICE consults on changes to Interventional Procedures guidance programme
Proposals now out for consultation seek to formalise the involvement of medical device manufacturers
Today (Thursday 29 November), NICE opens a public consultation on its preliminary recommendations on the NHS use of the drug, pirfenidone (known commercially as Esbriet). The draft guidance assesses whether it should be recommended for use in people who have the lung condition, idiopathic pulmonary fibrosis.
NICE does not recommend elusulfase alfa for NHS use following evaluation of new evidence
NICE has today (12 November 2021) published draft guidance for public consultation which does not recommend elosulfase alfa (also called Vimizin and made by BioMarin) for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
NICE has today (10 November 2020) published its draft updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS).
Draft guidance published today (8 March 2022) by NICE for public consultation does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer that has spread to other parts of the body.
Mesh for vaginal wall prolapse should only be used in the context of research, says NICE
Updated advice says current evidence on the safety of the procedure shows there are serious, but well-recognised safety concerns.
More women should be encouraged to give birth at midwife-led units rather than traditional labour wards, says NICE.
Minimum pricing for alcohol 'effectively targets harmful drinkers'
A minimum price per unit of alcohol, as recommended by NICE, effectively targets high-risk drinkers while having little impact on moderate drinkers, according to a new study.
Setting a minimum price per unit of alcohol, as recommended by NICE, will protect young people from the dangers of excessive drinking, according to a new report.